HOME >> BIOLOGY >> NEWS
Protein research illustrates how drugs fight malaria, other diseases

Parasite-caused diseases such as malaria kill millions of people each year, and eradication efforts have been largely futile.

But developing a clear understanding of how to exploit emerging information from genome research is the first step in developing effective, safe and affordable drugs that can combat many such diseases, said Pradipsinh Rathod, a University of Washington chemistry professor.

For instance, understanding how a single protein called DHFR is regulated in mammals and how it functions differently in the malaria-causing parasite Plasmodium eventually could mean a breakthrough in identifying other good targets for attacking Plasmodium and ultimately killing the deadly pathogen, Rathod said.

Rathod and former graduate student Kai Zhang, now a post-doctoral researcher at the Washington University School of Medicine in St. Louis, are co-authors of a paper detailing the work in the April 19 edition of the journal Science.

The work supports a shift in how scientists think about treating infectious diseases, improving on many of the increasingly ineffective remedies that are currently used, Rathod said.

"We are reinterpreting what has worked well previously, not just through a half-century-old standard for selective drug action but in the context of our most current understanding of how the cell works," he said. "By combining that reinterpretation with new tools developed in the last few years, we're discovering that there's a lot more to finding drugs that work well."

Much is being learned from the study of the human genome, and work on the malaria genome is expected to be finished this year, allowing for the first time a direct search for metabolic differences between host and parasite on an unprecedented scale, Rathod said. That in turn will inspire hunts for pharmaceuticals that will selectively kill parasites while doing minimum damage to the host cell.

"But such efforts will be futile if our model
'"/>

Contact: Vince Stricherz
vinces@u.washington.edu
206-543-2580
University of Washington
18-Apr-2002


Page: 1 2 3

Related biology news :

1. Protein is key to fatal disorder and normal cell function
2. Protein is key for digestive function of the pancreas
3. Proteins show promise for mosquito control
4. Protein involved in childhood disorder linked to cancer
5. Protein fishing in America: The movie
6. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
7. Protein key to trafficking in nerve terminals
8. Protein controls acid in cells by direct detection of volume changes, study finds
9. Protein believed to control formation of memory identified by Scripps & UCSD scientists
10. Protein stops blood-vessel growth, holds promise as cancer therapy
11. Proteins transform DNA into molecular velcro

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/14/2019)... ... November 13, 2019 , ... NDA ... RAC , a regulatory affairs and program management executive with more than 33 ... industries, has joined the firm as an Expert Consultant. , Robert Peterson ...
(Date:11/12/2019)... ... 2019 , ... In’Tech Medical SAS ( http://www.intech-medical.com ), the ... a Global Regulatory Affairs Department, to support Medical Device companies across its facilities. ... to any Medtech organization is more important than Research & Development, Manufacturing or ...
(Date:11/12/2019)... ... November 12, 2019 , ... G5, the leader in ... performance up to 25% and reduces cost-per-click by as much as 15%. An ... attribution (MTA) to predict best advertising outcomes and automatically allocate daily ad investments ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... ... November 12, 2019 , ... Fiberstar, Inc., ... and beverage industry launched a new innovative website. , After extensive research, ... website offers global visitors updated ingredient usage tables by food application and video ...
(Date:11/6/2019)... ... November 06, 2019 , ... ... collaboration and dialogue, today announces its East/West CEO conference to be ... Francisco. , Kicking off the week of the J.P. Morgan Healthcare ...
(Date:11/2/2019)... ... 31, 2019 , ... Join Patrick Raber, PhD, Manager, Research ... on Friday, November 15, 2019 at 1pm EST to learn about immunoSEQ ... T-cell receptors (TCRs) and B-cell receptors (BCRs), has been widely utilized to understand ...
(Date:10/29/2019)... HOUSTON (PRWEB) , ... October 29, 2019 , ... ... firm, is pleased to announce its Silver sponsorship and cold chain validation workshop ... La Jolla Torrey Pines in San Diego, California. , The Biomanufacturing World ...
Breaking Biology Technology:
Cached News: